Annual Report

Overview

The report presents FY22 as a year of strong consolidated growth, with total revenues reaching ₹1,308 Crore and continued expansion across international pharmaceutical markets. The company reports 3,000 direct and indirect employees at consolidated level. Its sustainability-related initiatives include zero discharge at all plants, local employment, internships, medical camps and disaster-relief support, alongside CSR projects in sanitation, healthcare, education and green-belt development.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2021-2022
Period: Ends 31 March 2022
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services